Correlation of immunohistochemical staining and mutations of p53 in human hepatocellular carcinoma.

被引：0
|
作者：
Hsia, CC
Nakashima, Y
Thorgeirsson, SS
Harris, CC
Wang, NJ
Momosaki, S
Tabor, E
机构：
[1] US FDA,DIV TRANSFUS TRANSMITTED DIS,BETHESDA,MD 20014
[2] NCI,NIH,BETHESDA,MD 20892
[3] QIDONG CANC INST,QIDONG,PEOPLES R CHINA
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1320 / 1320
页数：1
相关论文
共 50 条
  • [21] Clinical importance of gallstones and p53 mutations in carcinogenesis for gallbladder carcinoma.
    Hanada, K
    Hino, F
    Amano, H
    Ooe, H
    Hiramatsu, A
    Oobayashi, M
    Kajiyama, G
    Tsuchida, A
    GASTROENTEROLOGY, 2001, 120 (05) : A386 - A386
  • [22] Centrosome abnormalities in hepatocellular carcinoma: Correlation with p53 mutations, proliferative rate and tumor grade
    Witkiewicz, A
    Pihan, G
    Doxsey, S
    Pullman, J
    Banner, B
    MODERN PATHOLOGY, 2001, 14 (01) : 205A - 205A
  • [23] Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
    Yemelyanova, Anna
    Vang, Russell
    Kshirsagar, Malti
    Lu, Dan
    Marks, Morgan A.
    Shih, Ie Ming
    Kurman, Robert J.
    MODERN PATHOLOGY, 2011, 24 (09) : 1248 - 1253
  • [24] Immunohistochemical detection of p53 and p53 gene mutations in meningioma
    Hirato, J
    Sakurai, S
    Nakazato, Y
    BRAIN PATHOLOGY, 1997, 7 (04) : 1193 - 1193
  • [25] Immunohistochemical study of p53 and its relation to angiogenesis in urinary bladder carcinoma.
    Hammam, M
    Elokda, MO
    Youssef, WT
    Wagih, HM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 633 - 633
  • [26] High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma
    Anzola, M
    Saiz, A
    Cuevas, N
    Lopez-Martinez, M
    Martinez de Pancorbo, MA
    Burgos, JJ
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (06) : 502 - 510
  • [27] P53 MUTATIONS IN HUMAN HEPATOCELLULAR CARCINOMAS FROM GERMANY
    KRESS, S
    JAHN, UR
    BUCHMANN, A
    BANNASCH, P
    SCHWARZ, M
    CANCER RESEARCH, 1992, 52 (11) : 3220 - 3223
  • [28] Expression of MDR1 and mutant p53 protein in hepatocellular carcinoma.
    Grude, P
    Conti, F
    Louvel, A
    Lecureur, V
    Fardel, O
    Calmus, Y
    HEPATOLOGY, 1997, 26 (04) : 1314 - 1314
  • [29] P53 expression and proliferative activity in correlation to DNA-ploidy and TNM-classification in hepatocellular carcinoma.
    Schumacher, G
    Al-Abadi, H
    Spinelli, A
    Jonas, S
    Neuhaus, R
    Langrehr, JM
    Durr, A
    Neuhaus, P
    LIVER TRANSPLANTATION, 2005, 11 (07) : C73 - C73
  • [30] EXPRESSION OF P53 IN HUMAN ESOPHAGEAL-CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY WITH CORRELATION TO PCNA EXPRESSION
    SASANO, H
    MIYAZAKI, S
    GOUKON, Y
    NISHIHIRA, T
    SAWAI, T
    NAGURA, H
    LABORATORY INVESTIGATION, 1992, 66 (01) : A48 - A48
12345